Is chemotherapy used to treat multiple sclerosis?

Although the word is better known as a description of treatments for cancer, several chemotherapy drugs have been used in multiple sclerosis as disease modifying drugs. Chemotherapy is also used in stem cell therapies for MS.

What treatments are available for cholangiocarcinoma?

Treatments for cholangiocarcinoma (bile duct cancer) may include:

  • Surgery. When possible, surgeons try to remove as much of the cancer as they can.
  • Liver transplant.
  • Chemotherapy.
  • Radiation therapy.
  • Targeted drug therapy.
  • Immunotherapy.
  • Heating cancer cells.
  • Photodynamic therapy.

Can MS turn into cancer?

Background: Multiple sclerosis involves an abnormal immune response that damages the brain, spinal cord, and optic nerve. Since some emerging cancers can be eliminated by the immune system, there is a chance that people with MS could have an increased risk for cancer.

Are there any new treatments for cholangiocarcinoma?

FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts. Today, the U.S. Food and Drug Administration granted accelerated approval to Pemazyre (pemigatinib), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma.

Is there immunotherapy for cholangiocarcinoma?

The use of immunotherapy in the treatment of cholangiocarcinoma is still early in its development, it shows great promise. There are numerous ongoing trials looking at combining immunotherapies with other treatments in hopes of improving responses and outcomes in this aggressive disease.

What cancers are associated with MS?

However, the risk of certain cancers — such as central nervous system (brain, spinal cord and optic nerve) cancers and urinary cancers were around 50% higher in people with multiple sclerosis (MS). And respiratory cancers were about two-thirds more likely to occur in people with MS, the study found.

Does Immunotherapy work for cholangiocarcinoma?

Specifically, in the KEYNOTE028 study, 23 patients with cholangiocarcinomas were treated with pembrolizumab alone; 4 patients achieved partial remission and 4 patients had stable disease. These results suggested that immunotherapy may be a potential therapy for cholangiocarcinoma [25].

What country has the best treatment for MS?

In an analysis of multiple sclerosis registers from two different countries, researchers reported that Sweden’s trend toward starting with a highly effective disease-modifying therapy was associated with less worsening disability among patients when compared with those in Denmark, where the general tendency is to use …